An engineered strain for producing 2'-deoxyadenosine, its preparation method and application
By expressing the keto-deoxyadenosine reductase and adenylate dephosphatase genes in Corynebacterium glutamicum, the fermentation medium conditions are optimized, and the stability and cost problems of the existing 2'-deoxyadenosine preparation method are solved, and efficient and economical microbial fermentation production is achieved.
Patent Information
- Application Number
- CN202510669244.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-23
- Publication Date
- 2025-08-01
- Estimated Expiration
- 2045-05-23
AI Technical Summary
The existing preparation methods of 2'-deoxyadenosine have problems such as poor stability, low yield, high cost, and environmental pollution, which are difficult to meet market demand. Especially the low substrate concentration and high production cost of biological enzyme catalytic methods, which limits its large-scale application.
Corynebacterium glutamate was used as the host strain to express the ketodeoxyadenosine reductase gene cns1 and adenylate dephosphatase gene cns2 from Cordyceps sinensis. The fermentation medium conditions were ligated through plasmids and optimized to improve the yield and efficiency of 2'-deoxyadenosine.
Efficient production of 2'-deoxyadenosine was achieved in Corynebacterium glutamicum, with the fermentation yield of shake flasks reaching 239.3 mg/L, and the yield of 6L bioreactor reached 702.3 mg/L, which significantly improved the production efficiency and economy.
Smart Images

Figure CN120249164B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of microbial genetic engineering, and particularly relates to an engineered strain for producing 2'-deoxyadenosine, a preparation method thereof, and an application thereof. Background Art
[0002] 2'-deoxyadenosine (dAR) is one of the basic structural units of deoxyribonucleic acid (DNA) and has important biological functions and medicinal development values. In recent years, studies have shown that 2'-deoxyadenosine can not only inhibit glucose-induced insulin secretion but also promote insulin release by regulating specific phosphodiesterase inhibitors or adenylate cyclase activators. In addition, as an important intermediate for antiviral, anti-tumor, and anti-AIDS drugs, it also shows broad application prospects. At present, the preparation methods of 2'-deoxyadenosine mainly include DNA degradation method, chemical synthesis method, and biocatalytic method. However, the traditional DNA degradation method has poor stability and low yield; the chemical synthesis method has complex steps, high raw material costs, and environmental pollution, etc., which cannot meet market requirements; although the biocatalytic method is green and environmentally friendly, there are still problems such as low substrate concentration and high production costs, which limit its large-scale application. Therefore, there is an urgent need to develop a green, economical, and efficient microbial fermentation production process.
[0003] Corynebacterium glutamicum ( Corynebacterium glutamicum ) is an industrial microorganism widely recognized as a "Generally Recognized As Safe (GRAS)" strain, which has advantages such as strong robustness, no endotoxin, and mature genetic manipulation, and is widely used in the industrial production of important metabolites such as amino acids and organic acids. However, there is no report on the research of using Corynebacterium glutamicum as a chassis cell to synthesize nucleoside analogs such as cordycepin and 2'-deoxyadenosine. Summary of the Invention
[0004] Aiming at the deficiencies of the prior art, the technical problem to be solved by the present invention is to provide an engineered strain for producing 2'-deoxyadenosine, a preparation method thereof, and an application thereof.
[0005] To achieve the above technical purpose, the technical solution adopted by the present invention is as follows:
[0006] The present invention provides an engineered strain for producing 2'-deoxyadenosine, and the engineered strain expresses a ketodeoxyadenosine reductase gene cns1 and an adenylate dephosphatase gene cns2 .
[0007] Furthermore, cns1 and cns2 the genes both originate from Cordyceps militaris (Latin name: Cordyceps militaris )cns1 The nucleotide sequence of the gene is shown as SEQ ID NO.1; cns2 The nucleotide sequence of the gene is shown as SEQ ID NO.2.
[0008] The present invention also provides a method for preparing the above-mentioned engineered strain producing 2'-deoxyadenosine, comprising: ligating the ketodeoxyadenosine reductase gene cns1 and the adenosine monophosphate dephosphatase gene cns2 into an expression plasmid, and then transforming it into the host Corynebacterium glutamicum.
[0009] Preferably, the expression plasmid includes but is not limited to pEC-XK99E, pXMJ19, etc. Any plasmid that can satisfy the expression of the ketodeoxyadenosine reductase gene cns1 [[ID=…]] (the text seems to be incomplete here, but following the rules, I keep the original tags) and the adenosine monophosphate dephosphatase gene cns2 in Corynebacterium glutamicum is applicable to the present invention.
[0010] In some embodiments of the present invention, the expression plasmid is pXMJ19.
[0011] In some embodiments of the present invention, the above preparation method includes: first finding the gene sequences of the ketodeoxyadenosine reductase gene cns1 and the adenosine monophosphate dephosphatase gene cns2 from Cordyceps militaris on NCBI, and their sequences are shown as SEQ IDNO:1 and SEQ ID NO:2. According to the codon usage preference of Corynebacterium glutamicum, after codon optimization of cns1 and cns2 sequences, the gene sequences are artificially synthesized into the pUC57 plasmid to obtain the recombinant plasmid pUC57-cns1-cns2. Using the pUC57-cns1-cns2 plasmid as a template, amplify cns1 and cns2 genes, ligate the obtained gene fragments onto the pXMJ19 plasmid digested with Eco R I / Hin d III, screen to obtain the correct recombinant plasmid pXMJ19-cns1-cns2, and then transform the correct recombinant plasmid into the host Corynebacterium glutamicum to obtain the recombinant strain Cg-dAR.
[0012] The present invention further provides the application of the above-mentioned engineered strain producing 2'-deoxyadenosine in microbial fermentation. The main purpose of this application is to produce 2'-deoxyadenosine using the said engineered strain.
[0013] Preferably, the fermentation process includes: first, activating the engineered strain on a plate until monoclonal colonies grow, picking the monoclonal colonies and culturing them first in LBG medium, and then transferring them to a seed medium for culturing until the optical density (OD 562 ) value reaches between 2 and 10 to obtain a seed solution. The seed solution is then inoculated into a fermentation medium at an inoculation amount of 2% - 20% v / v for fermentation to obtain a fermentation broth containing the fermentation product.
[0014] More preferably, the formula of the seed medium is: 15 - 35 g / L sucrose, 5 - 15 g / L peptone, 1 - 10 g / L yeast powder, 1 - 10 g / L ammonium sulfate, 0.1 - 2 g / L magnesium sulfate heptahydrate, 1 - 10 g / L potassium dihydrogen phosphate, 5 - 15 g / L dipotassium hydrogen phosphate, 1 - 10 g / L urea, and the solvent is water; the culture conditions in the seed medium are: culturing at 28 - 34 °C and 200 - 250 rpm for 4 - 8 h.
[0015] More preferably, the components of the fermentation medium include a carbon source, a nitrogen source, inorganic salts, and cofactors, where:
[0016] The carbon source includes any one or a combination of two of glucose and molasses; preferably a combination of 20 - 50 g / L glucose and 10 - 30 g / L molasses, more preferably a combination of 30 g / L glucose and 20 g / L molasses;
[0017] The nitrogen source includes any one or a combination of several of yeast extract, ammonium sulfate, urea, corn steep liquor, peptone, and soybean meal powder; preferably a combination of 1 - 5 g / L corn steep liquor and 10 - 20 g / L ammonium sulfate, more preferably a combination of 3 g / L corn steep liquor and 12 g / L ammonium sulfate;
[0018] The inorganic salts include any one or a combination of several of H2PO4 - , K + , Mg 2+ , and Mn 2+ ; preferably a combination of 0.1 - 2 g / L phosphoric acid, 0.5 - 1.5 g / L magnesium sulfate heptahydrate, 0.1 - 5 g / L potassium chloride, and 50 - 200 mg / L manganese sulfate, more preferably a combination of 0.4 g / L phosphoric acid, 0.87 g / L magnesium sulfate heptahydrate, 0.53 g / L potassium chloride, and 100 mg / L manganese sulfate;
[0019] The cofactor comprises any one or a combination of glycine, adenine, adenosine, CuSO4, ZnSO4 and biotin; preferably a combination of 1-10 g / L glycine, 1-5 g / L adenine and 0.1-2 mg / L biotin, more preferably a combination of 5 g / L glycine, 2.5 g / L adenine and 1 mg / L biotin;
[0020] The fermentation culture conditions in the fermentation medium are: temperature 28-34°C, pH 6-7, aeration rate 2-8 vvm, and initial stirring speed 400-700 rpm.
[0021] More preferably, when the glucose concentration is lower than 1 g / L during the fermentation process, the dissolved oxygen value is controlled at about 30% by linking the dissolved oxygen and the rotation speed, and a feed sugar medium is added to maintain the glucose concentration at 1-2 g / L until the end of the fermentation; when the ammonium sulfate concentration is lower than 1 g / L during the fermentation process, a feed nitrogen medium is added to maintain the ammonium sulfate concentration at 1-1.5 g / L until the end of the fermentation.
[0022] More preferably, the above application further comprises: adding isopropyl-β-D-thiogalactopyranoside (IPTG) during the fermentation process; preferably adding 0.01-1 mM IPTG during the fermentation process; more preferably adding 1 mM IPTG.
[0023] More preferably, the fermentation process comprises: streaking the constructed engineered strain on a plate and culturing in a 30°C incubator for 24 h until a single clone grows, picking a single clone for activation and inoculating it into LBG medium, culturing it in a shaker at 30°C and 220 rpm for 12 h, and after activation, inoculating it into a baffled shake flask filled with seed culture medium at a 1% v / v inoculation rate, and culturing it at 30°C and 220 rpm until the OD 562It is 2 - 10. A seed solution is obtained and inoculated into a bioreactor containing a fermentation medium. The formula of the used fermentation medium is: 30 g / L glucose, 20 g / L molasses, 3 g / L corn steep liquor, 12 g / L ammonium sulfate, 0.4 g / L phosphoric acid, 0.87 g / L magnesium sulfate heptahydrate, 0.53 g / L potassium chloride, 100 mg / L manganese sulfate, 1 mg / L biotin, 5 g / L glycine, and 2.5 g / L adenine. The culture conditions are: the temperature is 30 °C, the pH is maintained at 6.5 using ammonia water, the initial aeration rate is 6 vvm, and the initial stirring speed is 550 rpm. When the glucose concentration in the fermentation process is lower than 1 g / L, the dissolved oxygen value is controlled at 30% through the linkage of dissolved oxygen and rotation speed, and a fed-batch sugar medium is added to maintain the glucose concentration at 1 - 2 g / L until the fermentation ends; when the ammonium sulfate concentration in the fermentation process is lower than 1 g / L, a fed-batch nitrogen medium is added to maintain the ammonium sulfate concentration at 1 - 1.5 g / L until the fermentation ends. Among them, the formula of the fed-batch sugar medium is 600 g / L glucose, 2 g / L magnesium sulfate heptahydrate, 1 g / L choline chloride, 0.1 g / L vitamin B1, 1 g / L potassium dihydrogen phosphate, and 1 mg / L biotin; the formula of the fed-batch nitrogen medium is 450 g / L ammonium sulfate.
[0024] Beneficial effects:
[0025] (1) In the present invention, the ketodeoxyadenosine reductase gene is expressed by plasmid in Corynebacterium glutamicum cns1 and the adenosine dephosphatase gene cns2 , and the yield of 2'-deoxyadenosine reaches 187.6 mg / L.
[0026] (2) By optimizing the fermentation medium conditions, the present invention improves the yield and efficiency of Corynebacterium glutamicum in synthesizing 2'-deoxyadenosine to varying degrees. Finally, when the initial fermentation medium pH = 6.5 and 5 g / L glycine and 2.5 g / L adenine are added simultaneously, the yield of 2'-deoxyadenosine is increased. The shake flask fermentation yield reaches 239.3 mg / L, and the yield of 2'-deoxyadenosine in a 6L bioreactor reaches 702.3 mg / L. Description of the drawings
[0027] The specification drawings forming a part of this application are used to provide a further understanding of the present invention. The schematic embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention.
[0028] Figure 1 It is the map of the expression plasmid pXMJ19-cns1-cns2, with a size of 10017 bp.
[0029] Figure 2It is a graph showing the change of 2'-deoxyadenosine produced by the engineered strain Cg-dAR over time.
[0030] Figure 3 It is the HPLC detection spectrum of 2'-deoxyadenosine in the fermentation broth of the engineered strain Cg-dAR.
[0031] Figure 4 It is the mass spectrometry identification graph of 2'-deoxyadenosine in the fermentation broth of the engineered strain Cg-dAR.
[0032] Figure 5 It is a schematic diagram for optimizing the concentration of adenine added to the fermentation medium for producing 2'-deoxyadenosine.
[0033] Figure 6 It is a schematic diagram for optimizing the concentration of adenosine added to the fermentation medium for producing 2'-deoxyadenosine.
[0034] Figure 7 It is a schematic diagram for optimizing the initial pH of the fermentation medium for producing 2'-deoxyadenosine.
[0035] Figure 8 It is a schematic diagram for optimizing the concentration of glycine added to the fermentation medium for producing 2'-deoxyadenosine.
[0036] Figure 9 It is a schematic diagram for optimizing the concentration of ZnSO4 added to the fermentation medium for producing 2'-deoxyadenosine.
[0037] Figure 10 It is a schematic diagram for optimizing the concentration of CuSO4 added to the fermentation medium for producing 2'-deoxyadenosine.
[0038] Figure 11 It is a graph showing the change of 2'-deoxyadenosine produced by the optimal combination obtained by orthogonal experiment using the engineered strain Cg-dAR over time.
[0039] Figure 12 It is a graph showing the change of 2'-deoxyadenosine produced by the engineered strain Cg-dAR in a 6L bioreactor over time. Detailed implementation manners
[0040] The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments, so that those skilled in the art can better understand the present invention and be able to implement it, but the specific embodiments cited are not intended to limit the present invention.
[0041] In the following embodiments, the experimental methods are all conventional methods unless otherwise specified; the reagents and materials can be obtained from commercial channels unless otherwise specified.
[0042] In the following embodiments, the plasmid pXMJ19 was purchased from Wuhan Miaoling Biotechnology Co., Ltd.
[0043] In the following examples, the host Corynebacterium glutamicum and the original strain of Corynebacterium glutamicum are both Corynebacterium glutamicum ATCC 13032.
[0044] In the following examples, the LBG plate (lysogeny broth medium supplemented with glucose) has the following formula: 10 g / L peptone, 5 g / L yeast extract, 10 g / L sodium chloride, 10 g / L glucose. 1.8% (v / v) agar powder is added to the solid medium.
[0045] The seed medium has the following formula: 25 g / L sucrose, 10 g / L peptone, 5 g / L yeast extract, 5 g / L ammonium sulfate, 1 g / L magnesium sulfate heptahydrate, 5 g / L potassium dihydrogen phosphate, 12 g / L dipotassium hydrogen phosphate, 5 g / L urea.
[0046] The fermentation medium consists of a carbon source, a nitrogen source, inorganic salts, and cofactors: the carbon source is a combination of 30 g / L glucose and 20 g / L molasses; the nitrogen source is a combination of 3 g / L corn steep liquor and 12 g / L ammonium sulfate; the inorganic salts are a combination of 0.4 g / L phosphoric acid, 0.87 g / L magnesium sulfate heptahydrate, 0.53 g / L potassium chloride, and 100 mg / L manganese sulfate; the cofactors are a combination of 5 g / L glycine, 2.5 g / L adenine, and 1 mg / L biotin.
[0047] First, according to the codon usage bias of Corynebacterium glutamicum, the cns1 gene and cns2 gene sequences (the sequences are shown as SEQ ID NO:1 and SEQ ID NO:2) from Cordyceps militaris were codon-optimized, and then the synthetic genes were inserted into the pUC57 plasmid to obtain the recombinant plasmid pUC57-cns1-cns2 for standby.
[0048] Example 1: Construction of the pXMJ19-cns1-cns2 expression plasmid
[0049] Using the pUC57-cns1-cns2 plasmid as a template and primers 1 / primers 2 (Table 1) as the upstream and downstream primers, the cns1 gene was amplified by PCR using the 2×Phanta Max Master Mix high-fidelity polymerase. Using the pUC57-cns1-cns2 plasmid as a template and primers 3 / primers 4 as the upstream and downstream primers, the cns2Genes. The PCR procedure was as follows: 95°C for 30 s, 55°C for 15 s, 72°C for 30 s / kb, for 30 cycles, and the PCR products were purified, and the purified products were verified by 1.5% agarose gel electrophoresis.
[0050] Table 1 Sequences of Primers 1 - 4
[0051]
[0052] The two PCR products obtained above were subjected to a one-step cloning ligation reaction with the plasmid fragment of pXMJ19 treated with restriction enzyme Hin d III / Eco R I in a reaction system. After screening, the recombinant plasmid pXMJ19-cns1-cns2 for expressing the ketodeoxyadenosine reductase gene cns1 and the adenylate dephosphatase gene cns2 was obtained. The plasmid map is shown in Figure 1 .
[0053] Example 2: Construction of Engineering Strains
[0054] The expression plasmid pXMJ19-cns1-cns2 constructed in Example 1 was electrotransformed (1800 V, 25 μF, 200 Ω, 2 mm) into Corynebacterium glutamicum ATCC 13032. The transformants were screened on LBG plates containing 6.5 μg / mL chloramphenicol after culturing for 2 - 3 days, and then colony PCR verification was carried out, thus obtaining the engineering strain expressing the ketodeoxyadenosine reductase gene cns1 and the adenylate dephosphatase gene cns2 , named Cg-dAR. Primers 5 and 6 were used for PCR verification to confirm that the genes on the expression plasmid pXMJ19-cns1-cns2 had entered the engineering strain Cg-dAR. The sequences of Primers 5 and 6 are shown in Table 2.
[0055] Table 2 Sequences of Primers 5 and 6
[0056]
[0057] Example 3: Identification of Fermentation Products of Engineering Strains
[0058] (1) The engineering strain Cg-dAR constructed in Example 2 was streaked on a plate and cultured in an incubator at 30°C for 24 h until single colonies grew out. Single colonies were picked and inoculated for activation in 5 mL of LBG medium and cultured in a shaker at 30°C and 220 rpm for 12 h. After activation, it was inoculated into a 500 mL baffled shake flask containing 50 mL of seed medium at an inoculation amount of 1% v / v and cultured at 30°C and 220 rpm until OD562 Around 8, a seed solution was obtained.
[0059] (2) The seed solution obtained in step (1) was inoculated into a 500 mL baffled shake flask containing 50 mL of fermentation medium at 10% v / v and cultured at 30 °C and 220 rpm for 72 h to obtain a fermentation broth. Subsequently, the fermentation broth was centrifuged at 12,000 rpm for 5 min to collect the supernatant, and the impurities were removed by filtration through a 0.22 μm filter membrane for subsequent detection and analysis. During the fermentation of the recombinant strain Cg-dAR, 6.5 μg / mL of chloramphenicol was added to the medium; in addition, IPTG with a final concentration of 1 mM was added during the logarithmic growth phase to induce the expression of the target gene.
[0060] (3) Detection of fermentation products: HPLC detection was performed using an Agilent 1260 Infinity II high-performance liquid chromatograph equipped with a variable wavelength detector (VWD) from Agilent Technologies. The chromatographic column was Poroshell 120 EC-C18, the mobile phase was acetonitrile and 0.3% trifluoroacetic acid (2:98, v / v) for isocratic elution, the flow rate was 0.6 mL / min, the column oven was set at 40 °C, and the signals of 2'-deoxyadenosine and other substances were detected at an absorbance of 260 nm. LC-MS / MS analysis was sent to Nanjing Jiangbei New Area Biomedical Public Service Platform Co., Ltd. (Nanjing, China) for analysis.
[0061] From Figure 3 and Figure 4 it can be seen that the engineered strains expressing genes cns1 and cns2 showed the same peak position as the 2'-deoxyadenosine standard, while the control strain containing the empty vector did not show a peak at the corresponding time. The LC-MS / MS results confirmed that the molecular weight of this peak was the same as that of the 2'-deoxyadenosine standard sample, and this peak was the peak of 2'-deoxyadenosine. The results showed ( Figure 2 ) that the 2'-deoxyadenosine yield of the engineered strain was 187.6 mg / L. Subsequently, the fermentation conditions of the engineered strain Cg-dAR were optimized.
[0062] Example 4: Optimization of fermentation medium
[0063] The medium is an essential nutrient matrix for the growth, reproduction of microorganisms and the synthesis of various metabolites. The components of the medium can significantly regulate the growth rate of the cells, the selectivity of the metabolic pathway and the yield of the target metabolite. Therefore, the components and culture conditions of the fermentation medium were systematically optimized in this application. The single-factor control variable method was adopted for optimization, and the culture was carried out at 30 °C and 220 rpm for 72 h, and the 2'-deoxyadenosine yield was measured.
[0064] (1) Different concentrations of the precursor adenine (0.1 g / L, 1 g / L, 2.5 g / L, and 5 g / L) were added to the fermentation medium, while the other culture conditions remained unchanged. Each combination was set with three replicates.
[0065] The results are as Figure 5 shown. When the concentration of the precursor adenine was 2.5 g / L, the yield of 2'-deoxyadenosine was the highest.
[0066] (2) Different concentrations of the precursor adenosine (0.1 g / L, 1 g / L, 2.5 g / L, and 5 g / L) were added to the fermentation medium, while the other culture conditions remained unchanged. Each combination was set with three replicates.
[0067] The results are as Figure 6 shown. When the concentration of the precursor adenosine was 2.5 g / L, the yield of 2'-deoxyadenosine was the highest.
[0068] (3) Different initial fermentation medium pH values (4.0, 5.0, 6.0, 7.0) were set, while the other culture conditions remained unchanged. Each combination was set with three replicates.
[0069] The results are as Figure 7 shown. When pH = 6.0, the yield of 2'-deoxyadenosine was the highest. Under the condition of pH = 7.0, the yield was not much different from that at pH = 6.0, indicating that both of these pH conditions were suitable for the synthesis of the product 2'-deoxyadenosine.
[0070] (4) Different concentrations of glycine (0 g / L, 5 g / L, 10 g / L, and 15 g / L) were added to the fermentation medium, while the other culture conditions remained unchanged. Each combination was set with three replicates.
[0071] The results are as Figure 8 shown. When the concentration of added glycine was 5 g / L, the yield of 2'-deoxyadenosine was the highest.
[0072] (5) Different concentrations of ZnSO4 (0.1 mM, 0.5 mM, 1 mM, and 2 mM) were added to the fermentation medium, while the other culture conditions remained unchanged. Each combination was set with three replicates.
[0073] The results are as Figure 9 shown. The addition of ZnSO4 was not very obvious in increasing the yield of 2'-deoxyadenosine. When the concentration of ZnSO4 was 0.5 mM, the yield of 2'-deoxyadenosine was the highest.
[0074] (6) Different concentrations of CuSO4 (0.1 mM, 0.5 mM, 1 mM, and 2 mM) were added to the fermentation medium, while the other culture conditions remained unchanged. Each combination was set with three replicates.
[0075] The results are as Figure 10 shown. When the concentration of added CuSO4 was 1 mM, the yield of 2′-deoxyadenosine was the highest.
[0076] Example 5: Optimization of the Optimal Culture Conditions for 2′-Deoxyadenosine Fermentation by Orthogonal Experiment
[0077] After optimizing the key parameters of 2′-deoxyadenosine fermentation through the single-factor experiment in Example 4 above, an orthogonal experiment with three factors and three levels was further designed to systematically evaluate the effects of various factors on the yield of 2′-deoxyadenosine. A total of 9 groups of orthogonal experiments were carried out, and each group had 3 parallel experiments. Fermentation experiments were carried out according to the parameters provided in Table 3. After 72 h of fermentation, HPLC was used to quantitatively analyze the content of 2′-deoxyadenosine in the supernatant of the fermentation broth.
[0078] Table 3 Orthogonal Experiment Factor-Level Table
[0079]
[0080] Table 4 Orthogonal Experiment Scheme and Results
[0081]
[0082] The fermentation results are shown in Table 4. The range R of adenine was the largest at 28.80, indicating that its effect on the dAR yield was the most significant; followed by glycine content, and the initial pH had a relatively small effect. The optimal combination was 2.5 g / L adenine, initial pH = 6.5, and 5 g / L glycine. The optimal culture conditions obtained from the experiment were verified, and the results are as Figure 11 shown. The optimized culture conditions increased the yield of 2′-deoxyadenosine to 239.3 mg / L, which was 27.6% higher than that of the unoptimized system.
[0083] Example 6: Production of 2′-Deoxyadenosine by the Engineered Strain in a 6L Bioreactor
[0084] The constructed engineered strain Cg-dAR was streaked on a plate and cultured in an incubator at 30 °C for 24 h until monoclonal colonies grew. A monoclonal colony was picked and inoculated into 5 mL of LBG medium and cultured in a shaker at 30 °C and 220 rpm for 12 h. After activation, it was inoculated into a 500 mL baffled shake flask containing 50 mL of seed medium at an inoculation amount of 1% v / v and cultured at 30 °C and 220 rpm until OD 562Around 8, a seed solution was obtained. 300 mL of the seed solution was inoculated into a 6 L bioreactor containing 1.8 L of fermentation medium. The fermentation medium used had the following formulation: 30 g / L glucose, 20 g / L molasses, 3 g / L corn steep liquor, 12 g / L ammonium sulfate, 0.4 g / L phosphoric acid, 0.87 g / L magnesium sulfate heptahydrate, 0.53 g / L potassium chloride, 100 mg / L manganese sulfate, 1 mg / L biotin, 5 g / L glycine, and 2.5 g / L adenine. Culture conditions: The temperature was 30 °C, ammonia water was used to maintain the pH at 6.5, the initial aeration rate was 6 vvm, and the initial stirring speed was 550 rpm. When the glucose concentration during fermentation was lower than 1 g / L, the dissolved oxygen value was controlled at around 30% through the linkage control of dissolved oxygen and rotation speed, and a feeding sugar medium was added to maintain the glucose concentration at 1 - 2 g / L until the end of fermentation; when the ammonium sulfate concentration during fermentation was lower than 1 g / L, a feeding nitrogen medium was added to maintain the ammonium sulfate concentration at 1 - 1.5 g / L until the end of fermentation. Among them, the feeding sugar medium had the following formulation: 600 g / L glucose, 2 g / L magnesium sulfate heptahydrate, 1 g / L choline chloride, 0.1 g / L vitamin B1, 1 g / L potassium dihydrogen phosphate, and 1 mg / L biotin; the feeding nitrogen medium had the following formulation: 450 g / L ammonium sulfate.
[0085] The results were as Figure 12 shown, and the yield of 2'-deoxyadenosine in the 6 L bioreactor reached 702.3 mg / L.
[0086] The present invention provides a method for synthesizing 2'-deoxyadenosine using Corynebacterium glutamicum. There are many specific methods and ways to implement this technical solution. The above description is only the preferred embodiment of the present invention. It should be noted that for those of ordinary skill in the art, without departing from the principle of the present invention, several improvements and refinements can be made, and these improvements and refinements should also be regarded as the protection scope of the present invention. Each component not clearly defined in this embodiment can be implemented using existing technologies.
Claims
1. An engineered strain for producing 2'-deoxyadenosine, characterized in that, The engineered strain expresses the ketodeoxyadenosine reductase gene in the host Corynebacterium glutamicum cns1 and the adenylate dephosphatase gene cns2 , cns1 and cns2 The genes are all derived from Cordyceps militaris, cns1 The nucleotide sequence of the gene is shown in SEQ ID NO.1; cns2 The nucleotide sequence of the gene is shown in SEQ ID NO.
2.
2. The preparation method of an engineered strain for producing 2'-deoxyadenosine according to claim 1, characterized in that, including: Connect the ketodeoxyadenosine reductase gene cns1 and the adenylic acid dephosphatase gene cns2 into an expression plasmid and then transform it into the host Corynebacterium glutamicum.
3. Use of an engineered strain for producing 2'-deoxyadenosine as claimed in claim 1 in the production of 2'-deoxyadenosine by microbial fermentation.
4. The application according to claim 3, wherein The fermentation process includes: First, activate the engineered strain on a plate until monoclonal colonies grow, pick the monoclonal colonies and culture them first in LBG medium, and then transfer them to a seed medium for culture until the optical density OD 562 value reaches between 2 and 10 to obtain a seed solution. Then, inoculate the seed solution into a fermentation medium at an inoculation amount of 2% - 20% v / v and ferment to obtain a fermentation broth containing the fermentation product.
5. The application according to claim 4, characterized in that, The formula of the seed medium is: 15 - 35 g / L sucrose, 5 - 15 g / L peptone, 1 - 10 g / L yeast powder, 1 - 10 g / L ammonium sulfate, 0.1 - 2 g / L magnesium sulfate heptahydrate, 1 - 10 g / L potassium dihydrogen phosphate, 5 - 15 g / L dipotassium hydrogen phosphate, 1 - 10 g / L urea, and the solvent is water; the culture conditions in the seed medium are: culture at 28 - 34°C and 200 - 250 rpm for 4 - 8 h.
6. The application according to claim 4, wherein The components of the fermentation medium include a carbon source, a nitrogen source, inorganic salts and cofactors, wherein: The carbon source includes any one or a combination of two of glucose and molasses; The nitrogen source includes any one or a combination of several of yeast extract, ammonium sulfate, urea, corn steep liquor, peptone and soybean meal powder; The inorganic salts described include H2PO4 - , K + , Mg 2+ and Mn 2+ or any combination of several of them; The cofactors include any one or a combination of several of glycine, adenine, adenosine, CuSO4, ZnSO4 and biotin; The fermentation culture conditions in the fermentation medium are: temperature 28 - 34°C, pH 6 - 7, aeration rate 2 - 8 vvm, initial stirring speed 400 - 700 rpm.
7. The application according to claim 6, wherein When the glucose concentration is lower than 1 g / L during the fermentation process, the dissolved oxygen value is controlled at 30% through the linkage of dissolved oxygen and rotation speed, and a feeding sugar medium is added to maintain the glucose concentration at 1 - 2 g / L until the end of fermentation; when the ammonium sulfate concentration is lower than 1 g / L during the fermentation process, a feeding nitrogen medium is added to maintain the ammonium sulfate concentration at 1 - 1.5 g / L until the end of fermentation.
8. The application according to claim 4, characterized in that It also includes: Isopropyl-β-D-thiogalactoside (IPTG) is added during the fermentation process.
9. The application according to claim 4, wherein The fermentation process includes: streaking the constructed engineering strain on a plate and culturing it in an incubator at 30 °C for 24 h until monoclonal colonies grow. Pick a monoclonal colony for activation and inoculate it into LBG medium, and culture it in a shaker at 30 °C and 220 rpm for 12 h. After activation is completed, inoculate it into a baffled shake flask containing seed medium at an inoculation amount of 1% v / v, and culture it at 30 °C and 220 rpm until OD 562 reaches 2 - 10 to obtain a seed solution. Inoculate the seed solution into a bioreactor containing fermentation medium. The formula of the fermentation medium used is: 30 g / L glucose, 20 g / L molasses, 3 g / L corn steep liquor, 12 g / L ammonium sulfate, 0.4 g / L phosphoric acid, 0.87 g / L magnesium sulfate heptahydrate, 0.53 g / L potassium chloride, 100 mg / L manganese sulfate, 1 mg / L biotin, 5 g / L glycine, and 2.5 g / L adenine. The culture conditions are: the temperature is 30 °C, the pH is maintained at 6.5 using ammonia water, the initial aeration rate is 6 vvm, and the initial stirring speed is 550 rpm. When the glucose concentration is lower than 1 g / L during fermentation, the dissolved oxygen value is controlled at 30% through the linkage control of dissolved oxygen and rotation speed, and a feeding sugar medium is added to maintain the glucose concentration at 1 - 2 g / L until fermentation ends; when the ammonium sulfate concentration is lower than 1 g / L during fermentation, a feeding nitrogen medium is added to maintain the ammonium sulfate concentration at 1 - 1.5 g / L until fermentation ends. Among them, the formula of the feeding sugar medium is 600 g / L glucose, 2 g / L magnesium sulfate heptahydrate, 1 g / L choline chloride, 0.1 g / L vitamin B1, 1 g / L potassium dihydrogen phosphate, and 1 mg / L biotin; the formula of the feeding nitrogen medium is 450 g / L ammonium sulfate.
Citation Information
Patent Citations
Engineered yeast for producing cordycepin and application
CN115975828A
Yeast engineering bacteria for high-yield cordycepin as well as construction method and application thereof
CN118291291A